BIVALIRUDIN INJECTION

avir pharma inc.🇨🇦 Health Canada

Approval Id: 123921b62a347c2b
Drug Approval Canada Name: BIVALIRUDIN INJECTION
Product Name: BIVALIRUDIN INJECTION
Status: Marketed
Status Date: 2021-03-05
Original Market Date: 2021-03-05
Din: 02505517
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 20:12.04.12
Atc Original: B01AE06 BIVALIRUDIN
Atc Name: b 01 ae 06
Aig Number: 0148342002
Company Name: avir pharma inc.
Company Address: 660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4

BIVALIRUDIN

5 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

123921b62a347c2b

Type

Standard